AC

Akarsh Chauhan

Active Director Director DIN 10195734
DIN 10195734 First appointment Jun 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Akarsh Chauhan

Data last updated:

Akarsh Chauhan is a Director at Jedex Infusion Private Limited (since 2023). The company operates in Paper. Jedex Infusion Private Limited reported revenue of ₹1.61 Cr (FY 2025).

DIN 10195734
Primary Designation Director
Industry Paper
First Appointment 07 Jun 2023
Oldest Company Age 3 yrs
Largest company Jedex Infusion Private Limited · ₹1.61 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jedex Infusion Private Limited U21001UP2023PTC183693
Director07 Jun 20232023₹1.61 Cr (FY 2025)Active

Board colleagues of Akarsh Chauhan

NameDINCompanyDesignation
Abhishek Singh09345109Jedex Infusion Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jedex Infusion Private Limited
Premium access

Shareholding and investment profile for Akarsh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akarsh Chauhan

Akarsh Chauhan currently holds 1 directorship: Jedex Infusion Private Limited (Director, since 07 Jun 2023, revenue ₹1.61 Cr (FY 2025)).

Akarsh Chauhan was first appointed on 07 Jun 2023 as Director at Jedex Infusion Private Limited.

The current boards of Akarsh Chauhan's companies include Abhishek Singh (Jedex Infusion Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available